Guangzhou LBP Medicine Science & Technology Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei	27.0%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Nov 06

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

Sep 30

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Apr 23

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Mar 09

Winst- en omzetgroeiprognoses

SHSE:688393 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2024	495	32	-8	18	N/A
6/30/2024	514	38	-27	16	N/A
3/31/2024	508	40	-28	11	N/A
12/31/2023	497	40	-21	17	N/A
9/30/2023	488	37	1	-4	N/A
6/30/2023	476	26	-33	-13	N/A
3/31/2023	478	31	-69	-8	N/A
12/31/2022	507	43	-62	10	N/A
9/30/2022	486	49	-143	27	N/A
6/30/2022	469	64	-115	48	N/A
3/31/2022	460	73	-103	58	N/A
12/31/2021	439	80	-84	60	N/A
9/30/2021	438	93	-22	99	N/A
6/30/2021	443	103	-17	74	N/A
3/31/2021	436	102	28	95	N/A
12/31/2020	375	85	29	91	N/A
9/30/2020	370	80	24	74	N/A
6/30/2020	344	75	65	102	N/A
3/31/2020	323	68	45	79	N/A
12/31/2019	355	74	54	90	N/A
12/31/2018	306	61	21	65	N/A
12/31/2017	260	48	N/A	84	N/A
12/31/2013	143	38	N/A	-1	N/A

Guangzhou LBP Medicine Science & Technology Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.21 in 3Q 2023)

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 27%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

New minor risk - Earnings quality

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

Guangzhou LBP Medicine Science & Technology Co., Ltd., Annual General Meeting, May 15, 2024

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Investor sentiment deteriorates as stock falls 18%

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment improves as stock rises 19%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.09 in 3Q 2022)

Less than half of directors are independent

Investor sentiment deteriorates as stock falls 21%

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023

Full year 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.85 in FY 2021)

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.85 in FY 2021)

Investor sentiment improves as stock rises 16%

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.09 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.29 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.86 (vs CN¥1.09 in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.43 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.33 in 2Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.09 (vs CN¥1.06 in FY 2019)

New 90-day low: CN¥34.43

New 90-day low: CN¥39.97

New 90-day low: CN¥42.73

Third quarter earnings released

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven